| Date | Time | Source | Headline | Symbol | Company |
| 08/29/2016 | 7:35AM | Business Wire | ARIAD to Present at the Morgan Stanley Global Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/23/2016 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/15/2016 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/08/2016 | 5:00PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/01/2016 | 4:02PM | PR Newswire (US) | PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/28/2016 | 7:36AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/28/2016 | 7:35AM | Business Wire | ARIAD Reports Second Quarter and First Half 2016 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/25/2016 | 4:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/22/2016 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/19/2016 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/19/2016 | 4:10PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/14/2016 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/07/2016 | 8:00AM | PR Newswire (US) | Biotechnology Equities Under the Scanner - Exelixis, Novavax, Celgene, and Ariad Pharma | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/05/2016 | 4:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/05/2016 | 7:35AM | Business Wire | ARIAD to Webcast Conference Call on Second Quarter 2016 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/29/2016 | 4:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/24/2016 | 7:35AM | Business Wire | ARIAD Announces Webcast of Its Annual Stockholders Meeting | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/23/2016 | 4:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/17/2016 | 12:33PM | Business Wire | ARIAD Completes Strategic Review and Announces Plans for Growth | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/17/2016 | 7:45AM | Business Wire | ARIAD Announces Distribution Agreements for Iclusig® in Latin America and the Middle East/North Africa | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/17/2016 | 7:35AM | Business Wire | ARIAD Initiates Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration Ahead of Plan | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/15/2016 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/14/2016 | 6:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/13/2016 | 7:35AM | Business Wire | ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2016 | 4:11PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2016 | 4:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2016 | 4:08PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2016 | 4:08PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/08/2016 | 7:35AM | Business Wire | ARIAD to Host Analyst & Investor Day in New York City | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 06/07/2016 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |